177 related articles for article (PubMed ID: 4005808)
1. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostate.
Droz JP; De Smedt E; Kattan J; Keuppens F; Khoury S; Mahler C; Denis L
Prostate; 1994; 24(2):62-6. PubMed ID: 7508621
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytopenia during diethylstilbestrol diphosphate (stilphostrol) infusion for carcinoma of the prostate.
Nachtsheim DA; McPherson RA; Pollen JJ; Schmidt JD
Prostate; 1980; 1(1):105-9. PubMed ID: 7279796
[TBL] [Abstract][Full Text] [Related]
4. Hypocalcemia associated with estrogen therapy for metastatic adenocarcinoma of the prostate.
Vogelgesang SA; McMillin JM
J Urol; 1988 Nov; 140(5):1025-7. PubMed ID: 3172354
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability, distribution and pharmacokinetics of diethystilbestrol produced from stilphostrol.
Abramson FP; Miller HC
J Urol; 1982 Dec; 128(6):1336-9. PubMed ID: 7154205
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience of hormone therapy to bone metastatic prostate cancer.
Wakisaka M; Nomura K
Int J Urol; 2006 May; 13(5):550-4. PubMed ID: 16771724
[TBL] [Abstract][Full Text] [Related]
7. [High dose fosfestrol in phase I-II trial for the treatment of hormone-resistant prostatic adenocarcinoma].
Kattan J; Droz JP; Culine S
Bull Cancer; 1993 Mar; 80(3):248-54. PubMed ID: 8173177
[TBL] [Abstract][Full Text] [Related]
8. Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer.
Hoshi S; Ohyama C; Hagisawa S; Ono K; Satoh M; Saito S; Fukuzaki A; Arai Y
Int J Clin Oncol; 2003 Apr; 8(2):118-20. PubMed ID: 12720106
[TBL] [Abstract][Full Text] [Related]
9. Moderate dose diethylstilbestrol diphosphate therapy in hormone refractory prostate cancer.
Takezawa Y; Nakata S; Kobayashi M; Kosaku N; Fukabori Y; Yamanaka H
Scand J Urol Nephrol; 2001 Sep; 35(4):283-7. PubMed ID: 11676353
[TBL] [Abstract][Full Text] [Related]
10. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
Wakisaka M; Takagishi H
Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
[TBL] [Abstract][Full Text] [Related]
11. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
Susan LP; Roth RB; Adkins WC
Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
[TBL] [Abstract][Full Text] [Related]
12. Role of estrogens in the secondary hormonal manipulation of hormone refractory prostate cancer.
Siddiqui K; Abbas F; Biyabani SR; Ather MH; Talati J
J Pak Med Assoc; 2004 Sep; 54(9):445-7. PubMed ID: 15518364
[TBL] [Abstract][Full Text] [Related]
13. Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer.
Yamamoto S; Yonese J; Kawakami S; Tsukamoto T; Ohkubo Y; Tatokoro M; Fukui I
Int J Clin Oncol; 2006 Aug; 11(4):326-8. PubMed ID: 16937308
[TBL] [Abstract][Full Text] [Related]
14. Management of adenocarcinoma of prostate with diethylstilbestrol diphosphate and cyclophosphamide.
Sinclair GR; Lupu AN; de Kernion JB
Urology; 1975 May; 5(5):665-8. PubMed ID: 48303
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications.
Citrin DL; Elson P; Kies MS; Lind R
Am J Med; 1984 May; 76(5):787-93. PubMed ID: 6539069
[TBL] [Abstract][Full Text] [Related]
16. Leuprolide versus diethylstilbestrol for metastatic prostate cancer.
Leuprolide Study Group
N Engl J Med; 1984 Nov; 311(20):1281-6. PubMed ID: 6436700
[TBL] [Abstract][Full Text] [Related]
17. Chemohormonal therapy of metastatic prostate cancer. A pilot study.
Citrin DL; Hogan TF; Davis TE
Cancer; 1983 Aug; 52(3):410-4. PubMed ID: 6861082
[TBL] [Abstract][Full Text] [Related]
18. Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate.
Sharifi R; Lee M; Ojeda L; Ray P; Stobnicki M; Guinan P
Urology; 1985 Aug; 26(2):117-24. PubMed ID: 3927551
[TBL] [Abstract][Full Text] [Related]
19. Initial chemotherapeutic trials in patients with inoperable or recurrent cancer of the prostate.
Tejada F; Cohen MH
Cancer Chemother Rep; 1975; 59(1):243-9. PubMed ID: 1131804
[TBL] [Abstract][Full Text] [Related]
20. Diethylstilbestrol in castration-resistant prostate cancer.
Wilkins A; Shahidi M; Parker C; Gunapala R; Thomas K; Huddart R; Horwich A; Dearnaley D
BJU Int; 2012 Dec; 110(11 Pt B):E727-35. PubMed ID: 23110500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
